András Inotai

Summary

Affiliation: Semmelweis University
Country: Hungary

Publications

  1. ncbi Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
    András Inotai
    University Pharmacy, Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary
    BMC Health Serv Res 12:332. 2012
  2. ncbi Determinants of NSAID choice in rheumatoid arthritis--a drug utilization study
    András Inotai
    Semmelweis University, University Pharmacy Department of Pharmacy Administration, H Budapest 1092, Hogyes Endre u 7 9, Hungary
    Acta Pol Pharm 69:773-7. 2012
  3. ncbi Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis
    András Inotai
    Semmelweis University, University Pharmacy Department of Pharmacy Administration, Hogyes Endre u 7 9, Budapest 1092, Hungary
    Rheumatol Int 32:963-9. 2012
  4. ncbi [Assessment of the pharmaceutical expenditure in Hungary]
    András Inotai
    Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Budapest, Hogyes E u 9 1092
    Acta Pharm Hung 80:162-72. 2010
  5. ncbi [The assessment of oral NSAID use in patients with rheumatoid arthritis in Hungary--a cross sectional non interventional study]
    András Inotai
    Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, 1092 Budapest, Hogyes E u 9
    Acta Pharm Hung 80:47-54. 2010
  6. ncbi Trends in the non-steroidal anti-inflammatory drug market in six Central-Eastern European countries based on retail information
    András Inotai
    University Pharmacy Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary
    Pharmacoepidemiol Drug Saf 19:183-90. 2010
  7. ncbi [Decision analytic modeling and their impact on health care decision making]
    András Inotai
    Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Budapest
    Acta Pharm Hung 79:63-9. 2009
  8. ncbi [Cost study of NSAID use in rheumatoid arthritis based on recent therapeutic protocols]
    András Inotai
    SemmeIweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Budapest, Hogyes E u 9 1092
    Acta Pharm Hung 78:79-86. 2008
  9. ncbi Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis
    András Inotai
    University Pharmacy Department of Pharmacy Administration, Semmelweis University, Hogyes Endre 7 9, Budapest, 1092, Hungary
    Int J Technol Assess Health Care 25:190-5. 2009
  10. ncbi Factors associated with medication adherence in patients with chronic obstructive pulmonary disease
    Tamás Agh
    University Pharmacy Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary
    Respiration 82:328-34. 2011

Collaborators

Detail Information

Publications11

  1. ncbi Attempt to increase the transparency of fourth hurdle implementation in Central-Eastern European middle income countries: publication of the critical appraisal methodology
    András Inotai
    University Pharmacy, Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary
    BMC Health Serv Res 12:332. 2012
    ..Our study aimed to develop a scientifically rigorous and detailed appraisal checklist for economic evaluations of pharmaceuticals in the single health technology assessment process...
  2. ncbi Determinants of NSAID choice in rheumatoid arthritis--a drug utilization study
    András Inotai
    Semmelweis University, University Pharmacy Department of Pharmacy Administration, H Budapest 1092, Hogyes Endre u 7 9, Hungary
    Acta Pol Pharm 69:773-7. 2012
    ..GI safe NSAIDs were much preferred in the RA study sample than in the total population. In conclusion, the NSAID medication of the observed 143 patients was considered to be reasonable regarding both cardiovascular and GI safety...
  3. ncbi Health-related quality of life and utility in patients receiving biological and non-biological treatments in rheumatoid arthritis
    András Inotai
    Semmelweis University, University Pharmacy Department of Pharmacy Administration, Hogyes Endre u 7 9, Budapest 1092, Hungary
    Rheumatol Int 32:963-9. 2012
    ..According to our knowledge, TTO was not used previously in Hungarian RA patients. Utility data concerning biological treatments are essential for cost-utility models in health technology assessment reports for public reimbursement...
  4. ncbi [Assessment of the pharmaceutical expenditure in Hungary]
    András Inotai
    Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Budapest, Hogyes E u 9 1092
    Acta Pharm Hung 80:162-72. 2010
    ..In order to improve the allocative efficiency of health care spending, available resources should be spent only on effective, cost-effective, economically affordable medicines...
  5. ncbi [The assessment of oral NSAID use in patients with rheumatoid arthritis in Hungary--a cross sectional non interventional study]
    András Inotai
    Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, 1092 Budapest, Hogyes E u 9
    Acta Pharm Hung 80:47-54. 2010
    ..No statistically significant difference in patient's quality of life could be proved between NSAID drug groups. The uses of NSAIDs were considered to be rational concerning CV and GI risk as well as cost-effectiveness...
  6. ncbi Trends in the non-steroidal anti-inflammatory drug market in six Central-Eastern European countries based on retail information
    András Inotai
    University Pharmacy Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary
    Pharmacoepidemiol Drug Saf 19:183-90. 2010
    ..The objective of this study was to evaluate the non-steroidal anti-inflammatory drug market of six Central and Eastern European countries. Trends and similarities were compared across the examined countries...
  7. ncbi [Decision analytic modeling and their impact on health care decision making]
    András Inotai
    Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Budapest
    Acta Pharm Hung 79:63-9. 2009
    ....
  8. ncbi [Cost study of NSAID use in rheumatoid arthritis based on recent therapeutic protocols]
    András Inotai
    SemmeIweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Budapest, Hogyes E u 9 1092
    Acta Pharm Hung 78:79-86. 2008
    ..We would also highlight the importance of individual therapy. In complex our purpose was to evaluate current therapeutic guidelines from a pharmacoeconomic perspective...
  9. ncbi Economic evaluation of nonsteroidal anti-inflammatory drug strategies in rheumatoid arthritis
    András Inotai
    University Pharmacy Department of Pharmacy Administration, Semmelweis University, Hogyes Endre 7 9, Budapest, 1092, Hungary
    Int J Technol Assess Health Care 25:190-5. 2009
    ..The aim of the study is to compare three therapeutic strategies: conventional NSAIDs, NSAID in combination with proton pump inhibitors (PPIs), and the selective COX2 inhibitor therapy (celecoxib)...
  10. ncbi Factors associated with medication adherence in patients with chronic obstructive pulmonary disease
    Tamás Agh
    University Pharmacy Department of Pharmacy Administration, Semmelweis University, Budapest, Hungary
    Respiration 82:328-34. 2011
    ..It is therefore necessary to identify factors associated with adherence to improve the effectiveness of COPD management within real-world situations...
  11. ncbi [Cost control techniques in Hungarian medicine reimbursement]
    András Inotai
    Semmelweis Egyetem, Egyetemi Gyógyszertár Gyógyszerügyi Szervezési Intézet, Budapest
    Acta Pharm Hung 77:190-6. 2007
    ....